---
title: "KATABI MAHA — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e41e2f1d-22c0-5583-bcc6-239a032af7d4
json: https://whiteintel.dev/api/public/dossier/e41e2f1d-22c0-5583-bcc6-239a032af7d4
identifier: sec:0001720685
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KATABI MAHA

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001720685`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e41e2f1d-22c0-5583-bcc6-239a032af7d4  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e41e2f1d-22c0-5583-bcc6-239a032af7d4  

## Ownership & control

### Holdings / subsidiaries

- **Vera Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/fe80b53a-7dca-5ddd-b38a-dd53db7882ef
- **AEROVATE THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/0498d804-2189-5885-b4d8-f0171a454d64
- **AEROVATE THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/0498d804-2189-5885-b4d8-f0171a454d64
- **RAYZEBIO, INC.** (director) — https://whiteintel.dev/entity/84c3a732-6df0-59c0-9df6-adef1b5b6dcf
- **Vera Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/fe80b53a-7dca-5ddd-b38a-dd53db7882ef
- **CINCOR PHARMA, INC.** (tenpercentowner) — https://whiteintel.dev/entity/adf7811b-e8f7-5a09-bb9c-b2275d2de9ea
- **BOLT BIOTHERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/a16ad017-8d37-51da-b504-fe5209392c9c
- **Inozyme Pharma, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/7fb05f43-aaa9-5234-a3e0-9d958c25cded
- **AKOUOS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/bb6adb1d-08b1-50ac-b661-f137cc05e729

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KATABI MAHA**. Human view: https://whiteintel.dev/entity/e41e2f1d-22c0-5583-bcc6-239a032af7d4 · Structured JSON: https://whiteintel.dev/api/public/dossier/e41e2f1d-22c0-5583-bcc6-239a032af7d4._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._